Pharma

Canadian real estate shows resilience in Q1 2024

Canada's commercial real estate remains strong in Q1 2024 despite slowing investment sales activity

Canadian real estate shows resilience in Q1 2024

Canada leads in new medicine approvals, outpacing OECD Median

Report shows Canada launches more new medicines than most OECD countries, with high-cost and specialty drugs dominating the market

Canada leads in new medicine approvals, outpacing OECD Median

CARP criticizes Bill C-64's limited coverage for seniors

CARP urges better focus and clarity in Bill C-64 to ensure seniors receive the medications they need

CARP criticizes Bill C-64's limited coverage for seniors

New advances in pancreatic cancer treatment

New advances in pancreatic cancer treatment

New advances in pancreatic cancer treatment

Call for national children's health strategy in Canada

Children's Healthcare Canada urges a strategic overhaul to prioritize and improve children's health nationwide

Call for national children's health strategy in Canada

New funding urged for PAH treatment in Canada

PHA Canada advocates for quick allocation of funds for rare disease medicines, spotlighting PAH's impact on work and life

New funding urged for PAH treatment in Canada